All News

2068 articles, sorted by publication time.

Clinical Trials · global

Triple-Hormone Drug Clears Two Phase 3 Trials, With Striking Weight Loss but Uncertain Cardiovascular Benefit

Retatrutide produced average weight loss of more than 20% in two high-risk populations—people with diabetes and those with established cardiovascular disease—giving Lilly the core clinical data needed for planned global submissions; however, an insufficient number of events means whether it can truly reduce cardiovascular risk remains inconclusive.

Genomic Medicine · us

After One-Person, One-Drug Therapies Leave the Lab, Who Reviews Them—and Who Pays? The Next Hurdle for Rare-Disease Gene Therapies

The newly established Center for Therapeutic Genetics is shifting the focus from whether a drug can be made for a single patient to a more difficult institutional challenge: how to accumulate reusable safety evidence and establish review and reimbursement pathways for therapies that serve only one person or a handful of people.

Drug Development · global

Opening Dozens of Pathways at Once With Light: Accelerating the Chemical Search for Nucleoside Antiviral Drugs

The research team replaced the time-consuming, separate construction of individual nucleoside molecules with an approach that starts from the same scalable core. The first batch of more than 70 compounds has shown anti-HIV signals, but a lengthy screening process remains before hits from cell-based assays can become usable drugs.

Biotechnology and Clinical Trials · global

Targeting Dormant Lesions Behind Sarcoma Recurrence: Healx Combination HLX-4310 Enters First-in-Human Trial

This oral combination, selected with AI assistance and subsequently validated in the laboratory, seeks to intervene in the biological mechanisms that allow micrometastatic lesions to remain dormant and later re-emerge; the first patient has been dosed, but at this stage the primary questions remain safety and an appropriate dose.

Cancer Research · asia

Adding Rare-Earth Ions to Extracellular Vesicles Amplifies Cancer Cells’ “Self-Recognition” Signal by More Than 25-Fold

A research team modified the surfaces of extracellular vesicles with lanthanide ions, greatly improving the speed and selectivity with which cancer cells recognize vesicles from the same source, and detected extremely small numbers of tumor cells in simulated blood samples; however, this diagnostic and delivery concept remains at the stage of cell and animal blood models.

Biomedical Artificial Intelligence · global

Making Chest X-Ray Decisions Traceable: CLEAR Breaks Black-Box Predictions Down into Clinical Concepts

This open model not only identifies imaging abnormalities but also attempts to explain the basis for its decisions: it links predictions back to hundreds of thousands of radiological observations, allowing physicians to inspect and correct the signals on which the model relies. But despite progress in transparency for research use, critical gaps remain before clinical safety and regulatory acceptance can be achieved.

Gene Therapy · us

Turning “One Person, One Drug” Into a Replicable Process: Three Major Institutions Establish Center for Therapeutic Genetics

Personalized genetic medicines for rare diseases are often time-consuming and expensive to develop, with each effort starting almost from scratch. A newly established nonprofit center aims to share design, manufacturing, and clinical frameworks, beginning with inherited childhood epilepsies to test whether this model can extend beyond a small number of exceptional cases.